Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.

NCT05911906 is registered in ClinicalTrials.gov with University of Derby as lead sponsor.

NCT NCT05911906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.
Lead sponsor
University of Derby
Phase
Phase 4
Overall status
Completed
Start date
October 8, 2024
Completion date
September 17, 2025
Enrollment
73 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection